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Abstract
Background: Physicians fear missing cases of pneumonia and treat many patients with signs of respiratory
infection unnecessarily with antibiotics. This is an avoidable cause for the increasing worldwide problem of
antibiotic resistance. We developed a user-friendly decision aid to rule out pneumonia and thus reduce the rate of
needless prescriptions of antibiotics.
Methods: This was a prospective cohort study in which we enrolled patients older than 18 years with a new or
worsened cough and fever without serious co-morbidities. Physicians recorded results of a standardized medical
history and physical examination. C-reactive protein was measured and chest radiographs were obtained. We used
Classification and Regression Trees to derive the decision tool.
Results: A total of 621 consenting eligible patients were studied, 598 were attending a primary care facility, were
48 years on average and 50% were male. Radiographic signs for pneumonia were present in 127 (20.5%) of
patients. Antibiotics were prescribed to 234 (48.3%) of patients without pneumonia. In patients with C-reactive
protein values below 10 μg/ml or patients presenting with C-reactive protein between 11 and 50 μg/ml, but
without dyspnoea and daily fever, pneumonia can be ruled out. By applying this rule in clinical practice antibiotic
prescription could be reduced by 9.1% (95% confidence interval (CI): 6.4 to 11.8).
Conclusions: Following validation and confirmation in new patient samples, this tool could help rule out
pneumonia and be used to reduce unnecessary antibiotic prescriptions in patients presenting with cough and
fever in primary care. The algorithm might be especially useful in those instances where taking a medical history
and physical examination alone are inconclusive for ruling out pneumonia
Background
Respiratory tract infections are the most frequent rea-
sons for unnecessary antibiotic prescriptions and inap-
propriate treatment with antibiotics is one of the
avoidable causes for the world-wide increasing problem
of antibiotic resistance [1-3]. Guidelines [4-6] and
patient information leaflets [7] emphasize this serious
problem by recommending antibiotics only for patients
with bacterial pneumonia and not for patients with
acute bronchitis or mild exacerbations of chronic
bronchitis [8,9]. The reasons for the still high rate of
inappropriate prescriptions in patients with cough and
fever are manifold [1]. An important and comprehensi-
ble one is that physicians do not want to miss the diag-
nosis of pneumonia. The problem in daily practice is
that no single symptom or clinical sign is pathognomo-
nic for the presence or absence of pneumonia, and dif-
ferentiation between pneumonia and non-pneumonia
based on single clinical signs is not possible.
While a normal chest x-ray, the reference test applied
in clinical practice, rules out pneumonia with a high
degree of certainty [10], recommendations discourage
performing an x-ray in every patient presenting with a
cough and increased body temperature. Costs are
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radiation unnecessarily [11]. An easy applicable diagnos-
tic aid to support primary care physicians in ruling out
pneumonia and to identify patients for whom treatment
with antibiotics is not necessary would be helpful but is
unavailable.
The aim of this study was the development of a diag-
nostic aid, based on clinical signs and the measurement
of C-reactive protein, to support physicians to safely
rule out pneumonia in patients with cough and fever
and to help in reducing unnecessary prescriptions of
antibiotics.
Methods
The ethics committees of the cantons of Zurich, St. Gal-
len and Thurgau approved the protocol and we obtained
informed consent from all participants.
General practitioners and directors of clinics in Inter-
nal Medicine in the eastern part of Switzerland were
invited to participate in this study. They received a letter
explaining the aim of the study. Physicians and direc-
tors, which confirmed participation, were provided with
detailed information about the study, including the
questionnaire to fill in information on patients’ histories,
findings on physical examination, lab results and X-ray
findings. In addition, they obtained patient information
leaflets and forms for written informed consent.
Patients aged 18 years and older with new or wor-
sened (at least 24 hours) coughs and subjective or mea-
sured increased body temperatures were eligible to enter
the study.
We excluded patients with known chronic lung dis-
eases (except chronic bronchitis), patients who devel-
oped cough and fever during their hospital stay, patients
with a positive HIV status or who were taking oral ster-
oids within the last month, patients on chemotherapy,
patients after organ transplantation, pregnant women,
and patients with a mental disorder or those incapable
of reading the information leaflet and/or giving
informed consent.
After getting informed consent, physicians performed
and recorded a standardized medical history and physical
examination. In addition, venous blood samples for C-
reactive protein were drawn from all patients and blood
was analyzed using standard procedures. Chest radio-
graphs, lateral and postero-anterior views, were obtained
from every patient after clinical examination irrespective
of whether the treating physician would have ordered
them outside this study. Physicians were asked to rate
infiltrates or other pulmonary abnormalities.
Physicians were free to order further tests; participat-
ing in the study had no influence at all on any treatment
and care of patients. Moreover, the result of the decision
rule was not available when treating patients.
The completed questionnaires and the radiographs
were sent to the study centre at the University Hospital
in Zurich. All radiographs were re-assessed by a senior
staff radiologist at the University Hospital. The radiolo-
gist was blinded to the clinical information and the
result of the assessment by the general physician. In
accordance with the BTS Guidelines for the Manage-
ment of Community Acquired Pneumonia in Adults we
defined pneumonia as a set of symptoms and signs con-
sistent with an acute lower respiratory tract infection
associated with radiographic shadowing for which there
is no other explanation (for example, no pulmonary
oedema or infarction) [10,12].
The questionnaire, including all the relevant informa-
tion to differentiate between pneumonia and acute
bronchitis, was developed in an iterative process by clin-
ical experts in the field [13]. The questionnaire, consist-
ing of 25 items, asked for information about age,
gender, symptoms (for example, duration of cough, spu-
tum production, and self-reported fever), results of phy-
sical examination (for example, respiratory rate,
abnormal breath sounds), the risk indicators (for exam-
ple, smoking history, indications for upper respiratory
tract infection), C-reactive protein level and findings in
chest x-ray. (Items included in the questionnaire are
shown in Table 1 together with summary statistics for
patients with and without pneumonia, separately.)
Statistical analysis
In a first approach, validating a previously published
expert-based diagnostic algorithm [13], we fitted a mul-
tiple logistic regression model to the binary outcome
variable pneumonia (yes/no). Independent variables
were the original set of clinical-diagnostic indicators (25
variables) [13]. Additionally, we included C-reactive pro-
tein. Due to the fact that a small number of missing
values occurred in some of the variables, and since we
considered these values to be missing at random, we
used a multiple imputation method based on chain
equations [14]. We imputed five datasets, and we esti-
mated the coefficients and their confidence intervals in
the multiple models based on a pooled fit over all five
of the imputed datasets. To quantify the discriminative
ability of the multiple models, we calculated a pooled
estimate of the area under the receiver operating charac-
teristic curve (AUC) for the five imputed datasets along
with the corresponding confidence interval.
We expected that our multiple model fits the data too
well, in the sense that any “unusual random feature in
the original data will be reflected in the predictions”,
but will not be replicated in a new set of observations
[15]. Therefore, we calculated the shrinkage factor
applying a leave-one-out cross validation in each of the
five imputed datasets. In order to obtain a conservative
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factor with the largest regression slope and deduced
shrunken regression coefficients for the final multiple
model (0.85 (corresponding intercept was 0.03).
Second, we used Classification and Regression Trees
(CART) in order to determine an easy-to use rule out
criterion for pneumonia [16]. In contrast to the multiple
models consisting of the complete set of 25 independent
variables, we aimed to find an applicable decision tree in
a GP setting. For that reason, we pre-selected six vari-
ables on the basis of ease of availability and reliability of
the information from the original set of indicators,
including chronic cough, daily fever, dyspnoea, respira-
tory rate, pleural friction rub, and C-reactive protein.
When developing the first exploratory tree using all 25
clinical-diagnostic indicators, we assigned a higher cost
to misclassifying a pneumonia-case than a non-case. We
later reduced the complexity of the tree by pruning
according to a complexity measure to get a decision
tree. In order to gain some idea about the tree’s validity,
it was developed on one dataset obtained from multiple
imputations and applied to the remaining four imputed
datasets.
Finally, we assessed the number of patients classified
as non-cases and the percentage of antibiotic prescrip-
tions that, in retrospect, could have been avoided in this
group. This means the diagnostic tool was applied post
treatment to assess whether or not these patients
Table 1 Comparison of patients with versus without pneumonia
Variate* All patients
(n = 621)
Patients without pneumonia
(n = 494)
Patients with pneumonia
(n = 127)
Age 46.7 (SD 16.3) 46.6 (SD 16.1) 46.8 (SD 17.2)
Gender (male) 308 (50%) 247 (50%) 61 (48%)
New onset/worsened cough’s duration (days) 7.0 (SD 9.6) 6.7 (SD 6.4) 8.4 (SD 17)
Chronic cough 43 (7%) 30 (6%) 13 (10%)
Daily fever 350 (56%) 266 (54%) 84 (66%)
Maximum temperature (°C) 38.5 (SD 1.0) 38.4 (SD 1.0) 38.8 (SD 1.0)
Dyspnea 223 (36%) 165 (33%) 58 (46%)
Dyspnea at effort only 117 (19%) 88 (18%) 29 (23%)
Wheezing 109 (18%) 85 (17%) 24 (19%)
Pain on inspiration 179 (29%) 133 (27%) 46 (36%)
Rigors 205 (23%) 150 (30%) 55 (43%)
Muco-purulent sputum 302 (49%) 240 (49%) 62 (49%)
Bloody sputum 42 (7%) 27 (5%) 15 (12%)
Cold/Influenza signs 301 (48%) 252 (51%) 49 (39%)
Non-Smoker 440 (71%) 349 (71%) 91 (72%)
Smoking (cigs./day) 16.4 (SD 9.1) 16.1 (SD 9.3) 17.6 (SD 8.7)
Pack years 12.7 (SD 18.2) 8.7 (SD 12.2) 25 (SD 26.7)
History of pneumonia 20 (3%) 17 (3%) 3 (2%)
Current temperature (°C) 37.4 (SD 1.0) 37.3 (SD 1.0) 37.7 (SD 1.0)
Signs of upper respiratory infection 234 (38%) 201 (46%) 33 (26%)
Respiratory rate (#/minute) 17 (SD 6) 16.6 (SD 5.7) 18.6 (SD 5.9)
Prolonged expiration 64 (10%) 48 (10%) 16 (13%)
Percussion: dullness (a) 38 (6%) 13 (3%) 25 (20%)
Auscultation: friction rub (b) 18 (3%) 7 (1%) 11 (9%)
Auscultation: diminished inspiratory sound (c) 74 (12%) 43 (9%) 31 (24%)
Auscultation: bronchial breath sound (d) 52 (8%) 28 (6%) 24 (19%)
Auscultation: rales and/or wheezing (e) 192 (31%) 144 (29%) 48 (38%)
Abnormalities in a to e, if 2+ in single locus 140 (23%) 84 (17%) 56 (44%)
Abnormalities in a to e, if 2+ in different loci 18 (3%) 10 (2%) 8 (6%)
C-reactive protein (CRP)
CRP 0 to 10 108 (17%) 108 (22%) 0 (0%)
CRP 11 to 50 265 (43%) 240 (49%) 25 (20%)
CRP 51 to 100 106 (17%) 78 (16%) 28 (22%)
CRP >100 134 (22%) 61 (12%) 73 (57%)
*Means and standard deviation; number of patients and percentages
Steurer et al. BMC Medicine 2011, 9:56
http://www.biomedcentral.com/1741-7015/9/56
Page 3 of 7actually needed antibiotic intervention. This was com-
pared to whether or not the patients had actually
received antibiotics. We tested whether the difference of
the two sample proportions p0, p1 of antibiotic prescrip-
tions with and without the CART decision rule was dif-
ferent from zero. For that we used the statistic
z=
p1 − p0
s.e.(p1 − p0)
, under the null-hypothesis that the true
unknown proportions π1 = π0 = π [[17], p. 152].
Results
A total of 245 physicians were invited to participate in
the study; 120 confirmed their participation and 86 phy-
sicians enrolled 642 patients between November 2006
and December 2009. We asked them to include all eligi-
ble patients consecutively.
Twenty-one patients had missing information about
pneumonia status and were not included in the final
analysis. The mean age was 46.8 years (standard devia-
tion (SD) 16.3), and 50% were male. A total of 598
patients attended a primary care physician and 23 (3.7%)
an emergency department in a hospital. The mean dura-
tion of cough until consultation was seven (SD 9.6)
days, in 548 (93%) cough was a symptom of recent
onset and 43 (7%) patients had chronic cough indicating
chronic bronchitis. All patients had subjective feelings of
increased body temperature, at the time of clinical
examination the mean body temperature was 37.4°C (SD
1.0). Body temperature at time of consultation was
≥38.5°C in 87 patients (14%). Detailed information about
symptoms and signs are shown in Table 1.
Radiographic signs for pneumonia were present in 127
(20.5%) of patients. Physicians prescribed antibiotics to
355 out of 609 patients (58%) (Information on antibiotic
prescription was missing for 12 participants). All but
four patients with pneumonia and 234 (38%) of patients
without radiological signs of pneumonia received a pre-
scription for antibiotics. (Information on antibiotics pre-
scription was missing in two cases with confirmed
pneumonia)
The results of the regression model can be found in
Table 2 and the final (shrunken) function is available in
Table 2 Pooled fit of the regression model based on 5 imputations*.
Variable OR Lower 95% CI Upper 95% CI P
Intercept 0.000 0.000 45.159 0.142
Age 0.969 0.948 0.991 0.008
New onset/worsened cough’s duration 1.030 0.996 1.065 0.084
Chronic cough 3.088 0.854 11.162 0.085
Daily fever 1.636 0.843 3.175 0.145
Maximum temperature (°C) 1.215 0.873 1.691 0.248
Dyspnea 1.270 0.535 3.017 0.586
Dyspnea at effort only 1.318 0.503 3.451 0.572
Wheezing 0.483 0.209 1.116 0.088
Pain on inspiration 0.767 0.385 1.529 0.448
Rigors 1.110 0.567 2.173 0.756
Muco-purulent sputum 0.626 0.344 1.138 0.124
Bloody sputum 3.071 1.150 8.203 0.025
Cold/influenza signs 0.644 0.326 1.271 0.200
Smoking 0.979 0.945 1.014 0.241
History of pneumonia 0.171 0.015 1.923 0.145
Current temperature (°C) 1.025 0.746 1.409 0.876
Signs of upper respiratory infection 0.622 0.304 1.272 0.188
Respiratory rate (#/minute) 1.041 0.988 1.097 0.128
Prolonged expiration 1.066 0.390 2.914 0.901
Percussion dullness (a) 2.214 0.761 6.440 0.144
Auscultation friction rub (b) 10.343 1.843 58.052 0.014
Auscultation: diminished inspiratory sound (c) 1.869 0.831 4.205 0.130
Auscultation: bronchial breath sound (d) 1.118 0.517 2.416 0.774
Auscultation: rales and/or wheezing (e) 0.886 0.403 1.950 0.763
Abnormalities in a to e, if 2+ in single locus 3.633 1.414 9.334 0.009
Abnormalities in a to e, if 2+ in different loci 4.472 0.337 59.294 0.223
CRP 1.017 1.012 1.022 0.000
Original dataset included 621 patients with data on pneumonia.
*Original dataset included 621 patients with data on pneumonia.
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characteristic curve was 0.90 (95% CI: 0.87 to 0.93).
Figure 1 shows the classification tree. According to
this tree, patients with C-reactive protein of below 10
μg/ml or patients presenting with C-reactive protein
between 11 and 50 μg/ml, but without dyspnea and
without daily fever can be classified as non-pneumonia
cases and a prescription of antibiotics is not necessary.
The complexity parameter of the tree was 0.04. The
number and classification of patients within the tree is
available in Additional file 2.
When we compared the proportion of antibiotic pre-
scriptions with and without the classification rule, we
found an overall potential reduction of antibiotic pre-
scriptions of 9.1 percentage points (95% CI: 6.4 to 11.8;
P < 0.001), and thus a significant reduction.
Sensitivity analyses
In order to assess the robustness of our decision rule,
we applied the tree to four datasets containing imputed
values for missing data. In three of the four datasets, no
single pneumonia case was misclassified when following
the rule described above. In one of the datasets, we mis-
classified one single patient with pneumonia, because
the corresponding C-reactive protein value was imputed
with a value of <10 μg/ml.
We also assessed whether the enrolment site had an
influence on our results. Repeating the analysis exclud-
ing 23 patients who had entered the study via the emer-
gency department in a hospital had no influence on the
reported findings.
Discussion
We developed a diagnostic instrument (a prediction
model) that allows calculating the probability of pneu-
monia in patients with new onset, or worsening, of a
chronic cough and increased body temperature. We also
derived a highly sensitive but simple clinical decision aid
to support physicians in ruling-out pneumonia with a
high degree of certainty and in consequence to reduce
unnecessary prescriptions of antibiotics. When the C-
reactive protein level is below 10 μg/ml or patients with
C-reactive protein levels between 11 and 50 μg/ml do
not complain about dyspnoea and daily fever since the
onset of a cough, pneumonia can be ruled out with a
high degree of certainty and unnecessary prescription of
antibiotics could significantly be reduced.
Our findings in the context of existing evidence
Our searches identified six prediction rules published in
five papers to calculate the probability of pneumonia
[18-22]. In three studies [19,21,22] only patients attend-
ing an emergency room and, in two of them, only
patients for which the physician ordered a chest x-ray
were included. In the study published by Melby, [20]
patients with normal blood sedimentation rate and/or
C-reactive protein levels were not included. These selec-
tions of patients may limit the application of the pub-
lished prediction rules in a primary care population.
Validation of these prediction rules in a small sample of
primary care patients showed only a moderate ability to
discriminate between patients with and without pneu-
monia [23]. In the prediction rule derived from primary
care patients published by Hopstaken, dry cough, diar-
rhoea and fever ≥38.5°C were indicators remaining in
the final multivariate model and C-reactive protein was
the strongest indicator as in our study [18].
Strength and limitations
The strength of our study is that over 90% of patients
were included by general practitioners and the reference
test for pneumonia was performed in all patients, mini-
mizing verification bias. However, the prevalence of
pneumonia in our sample is higher than in most other
studies. The prevalence of pneumonia in patients with
cough and fever ranges between 3 and 20% [24,25]. In a
study also performed in the primary care setting, the
prevalence was 13% [18]. The higher prevalence in our
population has at least two reasons. One is the fact that
the mean duration of cough until consulting a physician
was seven days, indicating more severe or protracted
respiratory tract infections. The second reason might be
that physicians did not include eligible patients consecu-
tively, but rather included patients with a longer dura-
tion of symptoms and probably higher suspicion of
pneumonia. Therefore, the results of our study are more
applicable to patients with am o r es e v e r eo rp r o t r a c t e d
course of infection of the lower respiratory tract and not
for all patients with new onset of cough and increased
body temperature.
A limitation of our study is that the results have not
been validated in a new, similar set of patients in gen-
eral practice. The internal validation techniques we used
are inferior to external validations. Not gathering infor-
mation about whether patients have diarrhoea is another
weakness of our study. This symptom has been shown
to be a relevant variable [18] in another prediction rule.
Finally, we did not assess the diagnostic value of Procal-
citonin, a relatively new marker for bacterial infections,
although it might be a better test than the C-reactive
protein to identify patients who should be treated with
antibiotics [26,27]. We decided against Procalcitonin
because the C-reactive protein is a widely used test
which requires only a finger prick and the result is avail-
able within a few minutes. In addition, compared to
Procalcitonin the cost for C-reactive protein measure-
ment is much lower. Arguably, assessing Procalcitonin
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our instrument.
Implications for practice
When physicians, after taking history and physical exam,
are in doubt whether pneumonia is present and pre-
scription of antibiotic treatment is indicated or not,
measuring the C-reactive protein concentration and
using the decision rule may be helpful in clinical prac-
tice. The rule helps in identifying a group of patients
where pneumonia is very unlikely and chest X-rays and
antibiotics are unnecessary. For the remaining patients
in which pneumonia cannot be ruled out, physicians
will order an X-ray and/or write a prescription for anti-
biotics and instruct them to start with antibiotics imme-
diately or after some days if symptoms remain.
Unnecessary prescription of antibiotics contributes to
the development of antibiotic resistance in the indivi-
dual patient with consequences on the societal level. It
is estimated that in the USA antibiotic resistance costs
between $21 to $34 billion annually [28]. Use of this
easy applicable decision aid by general practitioners will
contribute to reducing the worldwide manifest problem
of antibiotic resistance. Infections of the respiratory
tract are one of the most frequent reasons for inap-
propriate antibiotic prescriptions worldwide and even a
minor reduction in prescriptions of 10% could have
major consequences for individual patients and on the
societal level over time.
Implications for research
In further studies the decision aid to rule out pneumo-
n i as h o u l db ev a l i d a t e di np r i m a r yc a r ep a t i e n t sw i t h
cough and fever. Also, the probability function should
be validated in a new sample of patients. In further stu-
dies an optimal test-treatment strategy for patients in
which pneumonia cannot be ruled out with the decision
aid should be developed and validated by taking into
account the adverse effects of inappropriate prescrip-
tions of antibiotics and unnecessary chest X-rays.
Conclusions
Following validation and confirmation in new patient
samples, the decision aid to rule out pneumonia in
patients with a new onset of cough or worsening of
chronic cough and increased body temperature could
lead to a reduction in unnecessary prescription of anti-
biotics. Applying this fast and frugal algorithm, physi-
cians may reduce over-prescription of antibiotics and
contribute to decelerate the growing problem of bacter-
ial resistance.
Additional material
Additional file 1: This file provides the complete model along with
the shrunken coefficients.
Additional file 2: This file shows the classification tree to rule out
pneumonia.
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